Results 71 to 80 of about 47,294 (217)
Cardiogenic shock: do not forget the possibility of Kawasaki disease
We report the case of a six-year-old boy who presented with cardiogenic shock due to Kawasaki disease (KD). He was misdiagnosed at first as septic shock.
Wei Wang +4 more
doaj
Summary This case report is of educational value and contributes to the literature because it describes a unique death after anaesthesia due to cardiac tamponade from a rare cardiac neoplasm. In trying to diagnose the origin of chronic sinusitis, a geriatric mule mare was anaesthetised and during recovery, died acutely.
A. Carroll, J. Quandt, S. Dantino
wiley +1 more source
Abstract Background Infective endocarditis (IE) is a life‐threatening condition, and the surveillance of the incidence is important for monitoring disease trends. Administrative data routinely collected by hospitals offer a feasible and inexpensive method for surveillance of patients with IE, yet the accuracy of coding of IE, causative organisms and ...
Ruturaj Vaidya +14 more
wiley +1 more source
Clinical outcomes following shock team implementation for cardiogenic shock: a systematic review
Background Cardiogenic shock is a critical cardiac condition characterized by low cardiac output leading to end-organ hypoperfusion and associated with high in-hospital mortality rates.
Mohamed Abdelnabi +6 more
doaj +1 more source
Displays bar graphs showing outcome rates stratified by clinical and hemodynamic variables. Asterisks (*) denote statistically significant differences (p ≤ 0.05). “NS” indicates non‐significant comparisons. Percentages are shown above each bar. The top panel corresponds to acute kidney injury (blue bars), and the bottom panel corresponds to acute ...
Tess Calcagno +23 more
wiley +1 more source
Impacts of Hemodynamic Support on Ventricular Arrhythmia Ablation
ABSTRACT Background Data on the efficacy of hemodynamic support (HS) for protecting ventricular arrhythmia (VA) ablation in high‐risk heart failure (HF) patients with an impaired left ventricular function and its impact on mortality is limited. Objectives This study aimed to assess procedural efficacy, related complications, VA‐free survival, and ...
Denise Guckel +12 more
wiley +1 more source
Hypertrophic cardiomyopathy can be accompanied by dynamic obstruction in the left ventricular outflow tract and acute apical ballooning, which are among the very rare causes of cardiogenic shock. This condition requires a specific treatment approach that
Matej Strycek +3 more
doaj +1 more source
ABSTRACT Background Restrictive transfusion (Hb < 7 g/dL) is recommended for most perioperative patients, but the optimal threshold for those with cardiovascular disease or Hb 7–10 g/dL remains uncertain. The Perioperative Transfusion Trigger Score (POTTS), which integrates adrenaline requirement, FiO2, temperature, and angina history, may standardize ...
Shucong Liang +9 more
wiley +1 more source
Abstract Background Implantable cardioverter‐defibrillator (ICD) therapy relies on reliable right ventricular leads for pacing, sensing, and defibrillation. The INVICTA DF4 lead is an active‐fixation, quadripolar design intended to optimize implant workflow and long‐term safety and performance. Methods APOLLO was a prospective, multicenter, single‐arm,
Klaus K. Witte +13 more
wiley +1 more source
Biomarkers in cardiogenic shock: old pals, new friends
In cardiogenic shock, biomarkers should ideally help make the diagnosis, choose the right therapeutic options and monitor the patient in addition to clinical and echocardiographic indices.
Mathieu Jozwiak +3 more
doaj +1 more source

